Mesalamine Suspension
Product Images NDC 70954-301

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 70954-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Bottle)

Label for Mesalamine Rectal Suspension, USP Enema, containing 4 g/60 mL mesalamine in a rectal suspension dosage form. The label specifies use for rectal administration only and is distributed by ANI Pharmaceuticals, Inc. The label includes dosage instructions and storage conditions, along with a barcode and the NDC 70954-301-10.*

FDA Label Image

Carton (Carton)

Mesalamine 4 g/60 mL rectal suspension USP enema label from ANI Pharmaceuticals, Inc. The label indicates a 7-pack of 60 mL unit-dose bottles. It includes usage instructions stating it is for rectal use only and directions to shake well before using. Storage and safety warnings are also provided along with the NDC 70954-301-20 and distributor information.*

FDA Label Image

Fig-a (Fig A)

An instructional line drawing showing a hand holding a package with a marked seam. A second hand with scissors is positioned to cut along the seam, with an arrow and text indicating to "Grasp seam and tear down." This illustration depicts how to open the package, likely for a Mesalamine rectal suspension product.*

FDA Label Image

Fig-b (Fig B)

An instructional illustration showing two stages of handling a rectal medication applicator. The first part displays a hand holding the applicator with the protective sheath in place. The second part shows the applicator tip and nozzle being held, demonstrating readiness for use.*

FDA Label Image

Fig-c (Fig C)

Illustration showing the proper positioning of a person lying on their side with knees slightly bent, demonstrating the typical position for rectal administration of a medication suspension.*

FDA Label Image

Fig-d (Fig D)

An illustration showing a person in a kneeling position with the arms extended forward and the head down, which may depict a posture for administration or use of a rectal suspension medication.*

FDA Label Image

Fig-e (Fig E)

An instructional line drawing showing a person's hands preparing a rectal suspension dose. One hand holds a bottle, and the other hand is unscrewing or handling a cap, illustrating how to open the medication container for Mesalamine rectal suspension.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Mesalamine showing a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.